PAOLO BRIONES: Open Payments
NPI 1932617933 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,408 in 67 payments from 17 companies in 2025. Trend: 2023 $1,827 · 2024 $1,899 · 2025 $1,408
Food & beverage: $1,408
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 11 | $362 |
| Merck Sharp & Dohme LLC | 11 | $211 |
| Novartis Pharmaceuticals Corporation | 10 | $195 |
| Novo Nordisk Inc | 10 | $190 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $138 |
| BridgeBio Pharma, Inc. | 1 | $37 |
| Kestra Medical Technology Services, Inc. | 1 | $36 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $35 |
| Amgen Inc. | 2 | $32 |
| AtriCure, Inc. | 1 | $26 |
Products named: WATCHMAN FLX, LEQVIO, VERQUVO, Wegovy, JARDIANCE, Varithena Administration Pack, Ozempic, Attruby.
Industry payments across TX — which companies pay providers there.
